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CASE REPORT
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Abstract
Background: Sinus of Valsalva aneurysm (SOVA) is a rare anomaly of the aorta that can be congenital or acquired. It
can be associated with syndromes such as Marfan syndrome and Ehlers-Danlos syndrome. However, to our knowledge,
it has never been described in a patient with Apert syndrome. Although it often presents as an incidental ﬁnding on
imaging, SOVA is associated with the risk of serious complications, including rupture. A possible connection between
the conditions might be the FGFR2 gene mutation in Apert syndrome and the inﬂuence of a mutation in ﬁbroblast
growth factor 2 (FGF2) on heart development. Here we report a case of acute heart failure secondary to rupture of SOVA
into the right atrium in a patient with Apert syndrome.
Case presentation: A 47-year-old Caucasian woman with a history of Apert syndrome and rheumatoid arthritis presented with shortness of breath, orthopnea, paroxysmal nocturnal dyspnea, and progressive bilateral lower extremity
edema for 2 weeks. She was diagnosed with acute right heart failure due to ruptured SOVA. The patient underwent
surgical repair of the ruptured SOVA. Unfortunately, her postoperative course was complicated by a stroke leading to
brain death.
Conclusion: Ruptured SOVA is a quite rare but serious condition that can cause life-threatening complications. In this
case, SOVA occurred in a patient with Apert syndrome. The case may suggest that these two conditions may be related
through the FGFR2 gene mutation associated with Apert syndrome and the related growth factor FGF2 involved in heart
development.
Keywords: Right heart failure, Sinus of Valsalva aneurysm, Rupture of sinus of Valsalva aneurysm, Apert syndrome,
Case report

1. Introduction

A

pert syndrome is a rare autosomal dominant
disorder that results from mutations in the
ﬁbroblast growth factor receptor 2 (FGFR2) gene at
locus 10q26 (10q25-26). The prevalence of Apert
syndrome is approximately 15.5 in 1,000,000 live
births,1 and FGFR2 mutation incidence is reported
to be higher with advanced paternal age.2,3 Apert
syndrome is characterized by craniosynostosis,
craniofacial anomalies, and severe symmetrical
syndactyly of the hands and feet. Cardiovascular
abnormalities are present in 10% of patients,
including ventricular septal defect, atrial septal

defect, coarctation of the aorta, and patent ductus
arteriosus.4
To our knowledge, sinus of Valsalva aneurysm
(SOVA), has never been described in a patient with
Apert syndrome. Here we report a case of acute
heart failure secondary to rupture of SOVA into the
right atrium in a patient with Apert syndrome.

2. Case presentation
A 47-year-old Caucasian woman with history of
Apert syndrome and rheumatoid arthritis presented
with shortness of breath, orthopnea, paroxysmal
nocturnal dyspnea, and progressive bilateral lower
extremity edema for 2 weeks. The patient also
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reported a weight gain of 4.5 kg over the last 2
months prior to presentation. She was diagnosed
with Apert syndrome in childhood, but her earlier
medical records were not available. She did not
have any current or previous history of smoking or
alcohol use, and her family history was signiﬁcant
for heart failure in her maternal grandfather. Vital
signs were signiﬁcant for tachycardia up to 110 beats
per minute, temperature 36.4  C, blood pressure
141/77 mmHg, respiratory rate 18 breaths per minute, oxygen saturation 96% on room air. Her physical examination showed a 3/6 holosystolic murmur
in the right upper sternal border and elevated jugular venous pressure. She did not have other signs
of hyperdynamic circulation on examination. Laboratory studies were remarkable for elevated brain
natriuretic peptide 1205 pg/mL (normal value [NV]
<100 pg/mL), negative troponins, aspartate transaminase 102 U/L (NV 3-34 U/L), alanine transaminase 178 U/L (NV 15-41 U/L), and thyroidstimulating hormone 4.6 mIU/mL (NV 0.4-4 mIU/
mL).
Electrocardiogram (ECG) demonstrated sinus
tachycardia and left anterior fascicular block. Chest
x-ray revealed a small right-sided pleural effusion.
Computed tomography angiography scan of the
chest showed small bilateral pleural effusions and
cardiomegaly with reﬂux into the intrahepatic
veins, indicating right heart failure. Afterward, the
patient underwent a transthoracic echocardiogram
(TTE), which demonstrated normal ejection fraction, moderately enlarged right atrium and
ventricle, and abnormal increase in color ﬂow jet at
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the atrial septum. Transesophageal echocardiogram (TEE) was then done, which showed mildly
dilated aortic root, noncoronary SOVA with
possible communication to the right atrium, suggestive of ruptured SOVA (Fig. 1, Video). To
conﬁrm the diagnosis, the patient underwent cine
cardiac magnetic resonance imaging (MRI), which
was suggestive of communication between aortic
sinuses and the right atrium.
The patient was managed with IV diuresis until
she became euvolemic, then underwent repair of
the ruptured SOVA, reconstruction of the sinus of
Valsalva with a pericardial patch, and resuspension
of the aortic valve. The surgery was complicated by
bleeding and difﬁculty in liberating the patient from
the cardiopulmonary bypass machine, which resulted in a prolonged aortic cross-clamp time. She
required circulatory support with an intra-aortic
balloon pump and vasopressors. The surgical pathology report of the aortic root showed benign
aortic tissue with medial myxoid change and
adventitial hemorrhage with no granulomas or
malignancy. The aortic ﬁstula pathology showed
benign dense ﬁbroconnective tissue with reactive
changes, myxoid degeneration, and mild chronic
inﬂammation with no malignancy or granulomas.
After the surgery, the patient was moved to the
cardiovascular intensive care unit and was kept on
mechanical ventilation, intra-aortic balloon pump,
and vasopressors. On day 2 postoperatively, the
intra-aortic balloon pump was discontinued. However, she remained on vasopressor support and
developed ileus. Unfortunately, after weaning her

Fig. 1. Left: Transesophageal echocardiogram short axis. Arrow A, sinus of Valsalva aneurysm, arrow B, left noncoronary cusp, arrow C, coronary
cusp. Right: Transesophageal echocardiogram short axis with Doppler. Arrow D, sinus of Valsalva aneurysm. This view does not show rupture.
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Fig. 2. Surgical technique used for the repair of ruptured sinus of Valsalva aneurysm (RSVA) to the right atrium (RA). A, RSVA to the RA. B, Primary
closure of ﬁstulous communication. From Jung SH, Yun TJ, Im YM et al. Ruptured sinus of Valsalva aneurysm: transaortic repair may cause sinus of
Valsalva distortion and aortic regurgitation. J Thorac Cardiovasc Surg. 2008; 135 (5):1153e1158. Reprinted with permission.

off sedation in preparation for extubation, she was
unresponsive, with a ﬂaccid tone, ﬁxed dilated pupils, and absent corneal, pupillary, ocular cephalic,
vestibular cephalic reﬂex, and gag reﬂexes, which
prompted a head computed tomography (CT) scan
that showed a massive left cerebral hemisphere
stroke with midline shift and herniation. Subsequently, considering her neurological examination
and head CT scan ﬁndings, she was declared brain
dead.

3. Discussion
SOVA is an abnormal dilation of the area between
the aortic root annulus and the sinotubular ridge
(Fig. 2).5 Normally, the sinuses of Valsalva permit
the opening of the aortic valve during systole
without obstructing the coronary artery ostia. SOVA
is a rare anomaly that affects the right coronary
sinus in almost all cases, followed by the noncoronary sinus and left sinus.6
SOVA can be either acquired or congenital. Congenital aneurysms result from localized weakness of the
elastic lamina at the junction of aortic media and annulus
ﬁbrosus. This is usually seen in hereditary collagen diseases such as Marfan syndrome and Ehlers-Danlos
syndrome.6e9 Acquired aneurysms result from elastic
connective tissue degeneration leading to weakness of
the sinus wall, which can be caused by infectious diseases such as bacterial-endocarditis and syphilis and
from noninfectious diseases such as deceleration
trauma.10e12 Acquired SOVA can also be iatrogenic as a
complication of aortic valve replacement13e16 or
ascending aortic dissection repair.17
Ruptured SOVA has been reported in about 35%
of cases with only 25% presenting with acute

symptoms.17,18 The most common location of
rupture is the right ventricle, followed by the right
atrium.6 Complications of ruptured SOVA vary
depending on its anatomical location and communication with heart chambers (Fig. 2). In our case,
rupture of the non-coronary sinus led to communication between the aorta and the right atrium,
creating a left to right shunt and eventually rightsided heart failure.18,19
TTE and TEE are considered appropriate initial
imaging modalities in diagnosing ruptured SOVA,
which show continuous ﬂow in systole and diastole
on color Doppler.20,21 Cardiac CT scan also has been
used as a supplemental or conﬁrmatory test.22 Cine
cardiac MRI is considered the gold standard test.
However, it is not required if other imaging modalities sufﬁciently provide the diagnosis along with
pertinent anatomic and physiologic details.19
SOVA is classiﬁed as a lesion with moderate
complexity in the 2018 American Heart Association/
American College of Cardiology (AHA/ACC)
guidelines for the management of adults with
congenital heart disease.23 The mainstay of treatment is surgical, but there are no speciﬁc guidelines
for SOVA surgical repair. Transcatheter closure has
been reported in small number of cases in the
literature with promising results.23
Untreated ruptured SOVA carries a poor prognosis
with estimated mean survival of 1e2 years.24 However, surgical intervention has an excellent prognosis
in SOVA with estimated long-term survival of 90% at
15 years,25 and surgical in-hospital mortality is quite
low at 3.6%.26 We believe that our patient's poor
prognosis resulted from having a ruptured SOVA
and having a prolonged intraoperative aortic crossclamp time due to bleeding intraoperatively. To our

knowledge an association between Apert syndrome
and SOVA has not been previously described. It is
possible that this patient has two separate rare and
unrelated disorders. The alternative explanation is
that there is an association between Apert syndrome
and SOVA. Apert syndrome is caused by FGFR2 gene
mutation, and ﬁbroblast growth factor 2 (FGF2) is
involved in cell proliferation, angiogenesis, and heart
development.27 Heart defects are reported in 10% of
Apert patients.4 A mutation in FGF2 or its receptor
might theoretically lead to higher risk of developing
aneurysm.

4. Conclusion
Ruptured SOVA is a quite rare but serious condition
that can cause life-threatening complications. In this
case, SOVA occurred in a patient with Apert
syndrome. The case may suggest that these two conditions are related through the FGFR2 gene mutation
associated with Apert syndrome and the related
growth factor FGF2 involved in heart development.
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